Lipidor Ab
Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, AKP-03 for bacterial skin diseases, and AKP-07 for atopic dermat… Read more
Lipidor Ab (LIPI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.130x
Based on the latest financial reports, Lipidor Ab (LIPI) has a cash flow conversion efficiency ratio of -0.130x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.11 Million) by net assets (Skr16.29 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lipidor Ab - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Lipidor Ab's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lipidor Ab Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lipidor Ab ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
24SevenOffice Scandinavia AB
ST:247
|
-0.112x |
|
Hung Thinh Incons JSC
VN:HTN
|
N/A |
|
Coal Energy S.A.
WAR:CLE
|
0.080x |
|
Inch Kenneth Kajang Rubber PLC
KLSE:2607
|
0.018x |
|
Workhorse Group Inc
NASDAQ:WKHS
|
-0.343x |
|
Soligenix Inc.
NASDAQ:SNGX
|
-0.386x |
|
Luo Lih Fen Holding Co Ltd
TW:6666
|
0.012x |
|
K Seng Seng Corporation Bhd
KLSE:5192
|
0.144x |
Annual Cash Flow Conversion Efficiency for Lipidor Ab (2016–2024)
The table below shows the annual cash flow conversion efficiency of Lipidor Ab from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr7.72 Million | Skr-16.08 Million | -2.082x | -216.42% |
| 2023-12-31 | Skr-9.34 Million | Skr-16.70 Million | 1.789x | +109.84% |
| 2022-12-31 | Skr2.15 Million | Skr-39.00 Million | -18.174x | -5811.04% |
| 2021-12-31 | Skr43.52 Million | Skr-13.38 Million | -0.307x | -28.15% |
| 2020-12-31 | Skr63.66 Million | Skr-15.27 Million | -0.240x | +56.67% |
| 2019-12-31 | Skr26.83 Million | Skr-14.85 Million | -0.554x | -185.21% |
| 2018-12-31 | Skr14.45 Million | Skr-2.81 Million | -0.194x | +81.58% |
| 2017-12-31 | Skr3.48 Million | Skr-3.66 Million | -1.054x | +76.02% |
| 2016-12-31 | Skr833.68K | Skr-3.66 Million | -4.395x | -- |